Surgical considerations in liver transplantation: Small for size syndrome

Gennaro Selvaggi, A. Tzakis

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The chronic shortage of cadaveric grafts for patients on the liver transplant list has resulted in wide implementation of living donor liver transplant (LDLT) and split cadaveric liver transplantation (SLT). Small for size syndrome (SFSS) is a significant complication that can occur during LDLT or SLT. It is generally defined as the presence of prolonged cholestasis, coagulopathy and ascites within the first week from transplant Multiple factors contribute to the pathogenesis of SFSS, such as overall graft size, portal hyperperfusion, impaired venous outflow, as well as donor and recipient factors. Strategies utilized to minimize or resolve SFSS include the use of right lobe grafts, modulation of portal flow by splenic artery ligation, splenectomy or porto-systemic bypass, and optimization of venous outflow. Additional surgical techniques to avoid SFSS include the use of auxiliary orthotopic liver grafts and dual liver graft transplantation. Careful consideration of risk to the LDLT donor has to be taken whenever right lobe graft is utilized, especially if the middle hepatic vein (MVH) is going to be included in the graft.

Original languageEnglish
Pages (from-to)227-233
Number of pages7
JournalPanminerva Medica
Volume51
Issue number4
StatePublished - Dec 1 2009

Fingerprint

Liver Transplantation
Transplants
Living Donors
Liver
Tissue Donors
Splenic Artery
Hepatic Veins
Cholestasis
Splenectomy
Ascites
Ligation

Keywords

  • Liver transplantation
  • Living donor
  • Risk assessment

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Surgical considerations in liver transplantation : Small for size syndrome. / Selvaggi, Gennaro; Tzakis, A.

In: Panminerva Medica, Vol. 51, No. 4, 01.12.2009, p. 227-233.

Research output: Contribution to journalArticle

@article{72c6afc2d2fa42878859365cb3b276cc,
title = "Surgical considerations in liver transplantation: Small for size syndrome",
abstract = "The chronic shortage of cadaveric grafts for patients on the liver transplant list has resulted in wide implementation of living donor liver transplant (LDLT) and split cadaveric liver transplantation (SLT). Small for size syndrome (SFSS) is a significant complication that can occur during LDLT or SLT. It is generally defined as the presence of prolonged cholestasis, coagulopathy and ascites within the first week from transplant Multiple factors contribute to the pathogenesis of SFSS, such as overall graft size, portal hyperperfusion, impaired venous outflow, as well as donor and recipient factors. Strategies utilized to minimize or resolve SFSS include the use of right lobe grafts, modulation of portal flow by splenic artery ligation, splenectomy or porto-systemic bypass, and optimization of venous outflow. Additional surgical techniques to avoid SFSS include the use of auxiliary orthotopic liver grafts and dual liver graft transplantation. Careful consideration of risk to the LDLT donor has to be taken whenever right lobe graft is utilized, especially if the middle hepatic vein (MVH) is going to be included in the graft.",
keywords = "Liver transplantation, Living donor, Risk assessment",
author = "Gennaro Selvaggi and A. Tzakis",
year = "2009",
month = "12",
day = "1",
language = "English",
volume = "51",
pages = "227--233",
journal = "Panminerva Medica",
issn = "0031-0808",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - Surgical considerations in liver transplantation

T2 - Small for size syndrome

AU - Selvaggi, Gennaro

AU - Tzakis, A.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - The chronic shortage of cadaveric grafts for patients on the liver transplant list has resulted in wide implementation of living donor liver transplant (LDLT) and split cadaveric liver transplantation (SLT). Small for size syndrome (SFSS) is a significant complication that can occur during LDLT or SLT. It is generally defined as the presence of prolonged cholestasis, coagulopathy and ascites within the first week from transplant Multiple factors contribute to the pathogenesis of SFSS, such as overall graft size, portal hyperperfusion, impaired venous outflow, as well as donor and recipient factors. Strategies utilized to minimize or resolve SFSS include the use of right lobe grafts, modulation of portal flow by splenic artery ligation, splenectomy or porto-systemic bypass, and optimization of venous outflow. Additional surgical techniques to avoid SFSS include the use of auxiliary orthotopic liver grafts and dual liver graft transplantation. Careful consideration of risk to the LDLT donor has to be taken whenever right lobe graft is utilized, especially if the middle hepatic vein (MVH) is going to be included in the graft.

AB - The chronic shortage of cadaveric grafts for patients on the liver transplant list has resulted in wide implementation of living donor liver transplant (LDLT) and split cadaveric liver transplantation (SLT). Small for size syndrome (SFSS) is a significant complication that can occur during LDLT or SLT. It is generally defined as the presence of prolonged cholestasis, coagulopathy and ascites within the first week from transplant Multiple factors contribute to the pathogenesis of SFSS, such as overall graft size, portal hyperperfusion, impaired venous outflow, as well as donor and recipient factors. Strategies utilized to minimize or resolve SFSS include the use of right lobe grafts, modulation of portal flow by splenic artery ligation, splenectomy or porto-systemic bypass, and optimization of venous outflow. Additional surgical techniques to avoid SFSS include the use of auxiliary orthotopic liver grafts and dual liver graft transplantation. Careful consideration of risk to the LDLT donor has to be taken whenever right lobe graft is utilized, especially if the middle hepatic vein (MVH) is going to be included in the graft.

KW - Liver transplantation

KW - Living donor

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=77952363122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952363122&partnerID=8YFLogxK

M3 - Article

C2 - 20195233

AN - SCOPUS:77952363122

VL - 51

SP - 227

EP - 233

JO - Panminerva Medica

JF - Panminerva Medica

SN - 0031-0808

IS - 4

ER -